- Home
- GNFT vs PCF Comparison
GNFT vs PCF Comparison
Compare GNFT & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- PCF
- Stock Information
- Founded
- GNFT 1999
- PCF 1987
- Country
- GNFT France
- PCF United States
- Employees
- GNFT N/A
- PCF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- PCF Trusts Except Educational Religious and Charitable
- Sector
- GNFT Health Care
- PCF Finance
- Exchange
- GNFT Nasdaq
- PCF Nasdaq
- Market Cap
- GNFT 202.6M
- PCF 196.9M
- IPO Year
- GNFT 2019
- PCF N/A
- Fundamental
- Price
- GNFT $3.83
- PCF $6.78
- Analyst Decision
- GNFT Strong Buy
- PCF
- Analyst Count
- GNFT 1
- PCF 0
- Target Price
- GNFT $13.00
- PCF N/A
- AVG Volume (30 Days)
- GNFT 12.6K
- PCF 74.8K
- Earning Date
- GNFT 04-03-2025
- PCF 01-01-0001
- Dividend Yield
- GNFT N/A
- PCF 10.90%
- EPS Growth
- GNFT N/A
- PCF N/A
- EPS
- GNFT 0.47
- PCF N/A
- Revenue
- GNFT $86,225,222.00
- PCF N/A
- Revenue This Year
- GNFT $145.20
- PCF N/A
- Revenue Next Year
- GNFT N/A
- PCF N/A
- P/E Ratio
- GNFT $7.98
- PCF N/A
- Revenue Growth
- GNFT 175.45
- PCF N/A
- 52 Week Low
- GNFT $3.35
- PCF $5.71
- 52 Week High
- GNFT $6.42
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- GNFT 48.44
- PCF 57.99
- Support Level
- GNFT $3.69
- PCF $6.73
- Resistance Level
- GNFT $4.03
- PCF $6.87
- Average True Range (ATR)
- GNFT 0.16
- PCF 0.06
- MACD
- GNFT -0.00
- PCF 0.01
- Stochastic Oscillator
- GNFT 24.59
- PCF 55.00
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.